Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.

Abstract

The regional cerebral blood flow decreases in several cortical regions in AD patients with cognitive deterioration despite long-term AChEI therapy, similar to that observed in untreated patients, whereas it remains stable in AD patients with stabilized cognitive performance during therapy.